Dr. Jaspreet S. Sandhu, MD

Dr. Sandhu practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Sandhu's NPI, 1508843988, was assigned on December 28, 2005. Dr. Sandhu graduated from Wake Forest School of Medicine in 1998. Dr. Sandhu holds New York license 214493.

Dr. Sandhu's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Sandhu's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center (MSK), Department of Surgery. Dmand AI also links Dr. Sandhu to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sandhu practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Sandhu's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Sandhu is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dmand AI has Dr. Sandhu's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney cysts, kidney removal surgery, pelvic prolapse, prostate cancer and prostate inflammation or infection among the conditions Dr. Sandhu treats.

CMS data shows 1,471 Medicare services from Dr. Sandhu across 15 procedure codes in 2024, for 883 Medicare patients. Medicare paid $122,766 for them.

CMS counts 883 Medicare patients who saw Dr. Sandhu in 2024. The largest group is 75 to 84, with 389 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sandhu's median patient age at 76, with 17% women.

In 2024, Dr. Sandhu wrote 1,660 Medicare Part D claims for 468 patients. 77% of them were for generic drugs. CMS names the drug for 1,571 of them, across 20 drugs with 11 or more claims each, at $320,264 in total drug cost. In 2023, CMS named 1,605 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Sandhu for performance year 2024, reported as part of a group. Dr. Sandhu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sandhu as offering telehealth. CMS counts 13 procedures of prostate resection by Dr. Sandhu, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 113 papers to Dr. Sandhu, published from 2006 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Prostatectomy, Prostatic Neoplasms and Urinary Incontinence. Dr. Sandhu has published most often in J Urol. Dr. Sandhu's most frequent co-authors are James A. Eastham, MD, Oguz Akin, MD and Bernard H. Bochner, MD.

CMS Open Payments shows 206 general payments to Dr. Sandhu from 17 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Boston Scientific Corporation paid the most, $167,212.

Dr. Sandhu graduated from Wake Forest School of Medicine in 1998.

Dr. Sandhu is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.